Latest Capital Management News

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Bastion Minerals has entered a three-year At-The-Market subscription agreement with Dolphin Corporate Investments, unlocking up to $500,000 in standby equity capital with minimal dilution and full control over issuance timing.

Assetora Limited has raised $500,000 through a private placement, issuing 3.57 million shares with options attached, signaling strong investor confidence in its alternative assets strategy.

Dexus has priced a A$500 million subordinated notes issue, enhancing its financial flexibility and extending its debt maturity profile. The move reflects strong investor demand and strategic capital management.

Centuria Industrial REIT has announced a quarterly distribution of 4.2 cents per unit for December 2025, maintaining its steady income stream despite suspending its Distribution Reinvestment Plan.

Premier Investments Limited has announced an on-market share buy-back program valued up to $100 million AUD, set to commence in late December 2025 and run through 2026.

Premier Investments reported a robust FY25 with a 31% rise in net profit, driven by strong performances from Peter Alexander and Smiggle, alongside a strategic capital return plan including a $100 million share buyback.

Forrestania Resources has lodged a replacement bidder's statement for its off-market takeover offer of Kula Gold, offering 1 Forrestania share for every 5.6 Kula shares. The Kula board unanimously recommends acceptance, highlighting strategic benefits and operational synergies.

Fletcher Building has prepaid all US Private Placement notes, simplifying its capital structure and reducing interest costs, while extending key credit facilities to bolster liquidity.

BWP Property Group has announced a preliminary distribution estimate of 9.58 cents per stapled security for the six months ending December 2025, marking a 4.1% increase from the prior period. The distribution reinvestment plan (DRP) will be reinstated, offering investors a no-discount option to reinvest.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

Cash Converters has completed a $37.1 million acquisition of 29 franchise stores across Australia’s East Coast, aiming to boost earnings and operational efficiency from year one.